Navigation Links
MoleSafe USA Expands Services to Leading Cancer Facilities at St. Joseph's/Candler and CentraState Medical Center
Date:5/26/2010

MILLBURN, N.J., May 26 /PRNewswire/ -- MoleSafe (www.molesafe.com), the world's most advanced melanoma screening program, announced today that it will offer its services at two of the nation's top medical centers by the end of 2010.  The following institutions will soon offer in-house MoleSafe clinics to provide their patients with cutting-edge skin cancer detection:

  • The Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler (Savannah, Georgia)
  • CentraState Medical Center (Freehold, New Jersey)

"We could not be more proud to align MoleSafe with these highly regarded medical centers that have each done so much to save and improve the lives of skin cancer patients.  The rapid growth and expansion of MoleSafe is a promising sign that Americans are continuing to become better educated on the very serious threat posed by melanoma, a disease that needlessly takes the lives of thousands of people each year," said Dr. Richard Bezozo, president of MoleSafe USA.

The adoption of MoleSafe by these leading cancer facilities follows the recent announcement that MoleSafe is offered at the renowned NYU Ronald O. Perelman Department of Dermatology in New York.  Launched in the U.S. in 2008, MoleSafe has expanded rapidly throughout the United States.  In addition to its medical center partnerships, MoleSafe operates stand-alone clinics in San Francisco, California; Charlotte, North Carolina; Albuquerque, New Mexico; and Millburn, New Jersey.

In addition to his role as president and founder of MoleSafe USA, Dr. Richard Bezozo is the lead blogger for "Melanoma Updates", a blog that details the latest developing information and technology on skin cancer prevention and detection. (www.melanomaupdates.com)

MoleSafe is part of an international network of forty melanoma screening centers located primarily in Australia and New Zealand, which have the highest rates of melanoma.  Using advanced technology developed by MoleMap New Zealand, Ltd, this network of clinics has conducted more than 135,000 examinations on 75,000 patients, imaged and diagnosed in excess of 1.5 million lesions, identifying close to 1,500 melanomas.

The MoleSafe four-pronged procedure represents a new standard of care and is part of a life-long program for the early detection of melanoma. It has four key elements:

  • Risk assessment: Using its database, MoleSafe has developed a risk assessment model that can help identify patients who may be at higher risk of melanoma;
  • Serial Digital Dermoscopy: Individual moles are imaged microscopically, and tagged to their location on the body for subsequent diagnosis, identification and comparison over time;
  • Diagnosis and Management: The patient's complete skin record, including digital images and clinical information, is sent via a secure tele-dermatology network to MoleSafe's panel of world-class melanoma dermatologists (dermoscopists) for analysis and reporting. Patients and their designated doctors receive their reports and their digital melanogram.
  • Education and Follow-up: The MoleSafe melanographer, a trained nurse, nurse practitioner or physician assistant educates patients about the risks of sun exposure, and helps generate a continuing partnership between MoleSafe, the patient and his/her doctor.  

To schedule an appointment for a MoleSafe screening at any one of these new locations, call 877-MOLESAFE (877- 665-3723).

About MoleSafe

MoleSafe (www.molesafe.com) is a state-of-the-art procedure involving the digital imaging, archiving and diagnosis of moles and other suspicious lesions. The procedure utilizes a combination of high resolution dermoscopy imaging technology that uses high intensity light to penetrate through the surface of the skin to show the structure of moles (and other lesions) and a dermatologist's expert evaluation of the images. In addition to the increased diagnostic accuracy associated with dermoscopy, MoleSafe is able to detect at an earlier stage any new, changing and/or suspicious lesions by monitoring and comparing the images over time. While MoleSafe has the ability to identify all skin cancers, its primary focus is on the early detection of melanoma.


'/>"/>
SOURCE MoleSafe
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waters Expands Xevo MS Instrument Platform With Next-Generation Mass Spectrometers
2. West Haven Firm Expands Biomedical Disposal Program with Community Economic Development Fund
3. Connectyx Retains Services of CP Capital Securities as It Expands Its Presence in the $5 Billion US Electronic Health Record Market
4. SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies
5. Eye-Fi Expands Hotspot Access Service Worldwide
6. MyPunchbowl Expands Leadership Team With Veterans of Evite.com and Pizza Hut
7. Healthcare Web Site Expands Reach to Pharmacy Industry
8. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.
9. URL Pharma Expands Colcrys(R) Patient Assistance Program
10. HIV Vaccine Strategy Expands Immune Responses
11. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... Dr. Vivek Ahuja , George ... phen Schmidt Join the Growing Organization ... for life sciences, today announced key new leaders have joined the ... a growing business.  This will bolster the company,s safety business unit ... ArisGlobal in the position of Vice President - Safety. George has ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... ... Coast Dental Fort Stewart is celebrating its grand opening with an open ... Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, giveaways, and ... the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, DMD, and ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Mobility Designed ... put pressure on the armpits, the M+D Crutch evenly distributes body weight from the ... wrists and hands when using the crutches than with other crutches. , Co-founders Max ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
Breaking Medicine News(10 mins):